Open AccessHuman papillomavirus vaccination update: Nonavalent vaccine and the two-dose schedule
Author(s) -
Julia Brotherton
Publication year - 2018
Publication title -
australian journal of general practice
Language(s) - English
Resource type - Journals
eISSN - 2208-7958
DOI - 10.31128/ajgp-01-18-4462
Subject(s) - medicine , vaccination , cervical cancer , human papillomavirus vaccine , human papillomavirus , genital warts , hpv vaccines , schedule , cohort , oncology , hpv infection , cancer , immunology , gardasil , computer science , operating system
Australia has included quadrivalent human papillomavirus (HPV) vaccination in its national program since 2007. Significant declines have been observed in the incidence of HPV infection, genital warts and high-grade cervical lesions. In 2018, the program changed to a nonavalent HPV vaccine administered over a routine two-dose schedule for the target cohort of adolescents aged 12-13 years.